|
|
#1
05-29-2015, 11:38 PM
|
|||
|
|||
Bristol?s Opdivo reduces risk of death from common lung cancer
Chicago (Reuters) - Bristol-Myers Squibb Co's drug, Opdivo, improved survival for patients with the most common form of lung cancer, nearly doubling survival for those with high levels of a specific protein in their tumors compared with chemotherapy, according to clinical trial results presented on Friday.  ??????? ??????: Bristol?s Opdivo reduces risk of death from common lung cancer || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
